Venlafaxine Hydrochloride Capsule, Extended Release
FDA Label NDC 70771-1836

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Venlafaxine Hydrochloride (NDC 70771-1836). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

NDC 70771-1836-9

Venlafaxine Hydrochloride Extended-release Capsules USP, 37.5 mg

90 Capsules

Rx only

37.5 mg Label (665f7293 1792 4b57 B8af 3e1fc33e8200 01)

37.5 mg Label (665f7293 1792 4b57 B8af 3e1fc33e8200 01)

NDC 70771-1837-9

Venlafaxine Hydrochloride Extended-release Capsules USP, 75 mg

90 Capsules

Rx only

75 mg Label (665f7293 1792 4b57 B8af 3e1fc33e8200 02)

75 mg Label (665f7293 1792 4b57 B8af 3e1fc33e8200 02)

NDC 70771-1838-9

Venlafaxine Hydrochloride Extended-release Capsules USP, 150 mg

90 Capsules

Rx only

150 mg Label (665f7293 1792 4b57 B8af 3e1fc33e8200 03)

150 mg Label (665f7293 1792 4b57 B8af 3e1fc33e8200 03)

* Please review the disclaimer below.